1. Unraveling survivin expression in chronic myeloid leukemia: Molecular interactions and clinical implications
   Paula Sabbo Bernardo et al, 2020, Blood Reviews CrossRef
2. Isoalantolactone mediates the degradation of BCR-ABL protein in imatinib-resistant CML cells by down-regulating survivin
   Shan-Shan Yin et al, 2023, Cell Cycle CrossRef
3. Dynamic Monitoring of CD200 Mediated by Ascites-Derived Exosomes as a Predictor of Survival and Response to Front-Line Chemotherapeutics in Advanced High-Grade Serous Ovarian Cancer
   Ying Ji et al, 2023, Clinical and Experimental Obstetrics & Gynecology CrossRef
4. Implementation of docking, molecular dynamics and free energy to investigate drug potency of novel BCR-ABLT315I inhibitors as an alternative to ponatinib
   Mohammad Mahmoudi Gomari et al, 2021, Computational Toxicology CrossRef
5. A novel tropomyosin-related kinase A inhibitor, KK5101 to treat pancreatic cancer
   Zhenghuan Fang et al, 2018, Cancer Letters CrossRef
6. An ethyl acetate fraction of Artemisia capillaris (ACE‐63) induced apoptosis and anti‐angiogenesis via inhibition of PI3K/AKT signaling in hepatocellular carcinoma
   Kyung Hee Jung et al, 2018, Phytotherapy Research CrossRef